Post by Alnylam Pharmaceuticals
290,476 followers
That's a wrap on #PNS2026! Thank you to the neurology community for a week of meaningful discussion and exchange. We’re encouraged by the continued focus on earlier recognition and intervention in hereditary transthyretin #amyloidosis with polyneuropathy (hATTR-PN) and appreciated connecting with those dedicated to improving outcomes for patients.
Video Content